Tradestie Institutional Equity Comparison Engine

HSTM vs SABA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HSTM Overall Edge

HSTM Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HealthStream Inc (HSTM) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, HSTM trades at 28.6x Forward P/E with 7.8% operating margin (+8.9% YoY revenue) versus SABA at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HSTM sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against SABA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner HSTM
HSTM 28.6x vs SABA N/M Fwd P/E
Growth & Margin Winner HSTM
Op Margin 7.8% vs N/A ยท YoY +8.9% vs N/A
Momentum & Technical Winner HSTM
1Y +6.8% vs -16.0% ยท 52W Pos 42% vs 4%
Options & Structure Winner HSTM
UNCLASSIFIED (50th %ile IV) vs UNCLASSIFIED (N/A IV)
HSTM NASDAQ
HealthStream Inc
Services-Computer Programming, Data Processing, Etc.
$26.29
+0.19% 1D
Market Cap $802.8M
1M Return -24.0%
1Y Return +6.78%
Forward P/E 28.6x
Unified AI Score
50.5 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
SABA NYSE
Saba Capital Income & Opportunities Fund II
Institutional Equity
$7.33
-0.27% 1D
Market Cap $251.8M
1M Return -3.68%
1Y Return -16.04%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 38.0 Fund 55.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HSTM +6.78% SABA -16.04% Spread: +22.82 pp (HSTM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HSTM TTM Op. Margin: 7.8% SABA TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HSTM vs SABA. Trailing 12-month operating profitability (HSTM 7.8% vs SABA N/A) and valuation multiples (HSTM 28.6x vs SABA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HSTM (9) vs SABA (1)
Institutional Metric HSTM SABA Criterion Row Winner
Market Capitalization Scale $802.8M $251.8M Larger Scale HSTM
Trailing P/E Ratio Valuation 37.5x N/M Lower Multiple HSTM
Forward P/E Ratio Valuation 28.6x N/M Lower Multiple HSTM
Revenue Growth (YoY) Growth +8.9% N/A Higher Growth HSTM
Operating Margin (TTM) Profitability 7.8% N/A Higher Margin HSTM
Net Profit Margin Profitability 6.2% N/A Higher Margin HSTM
Return on Equity (ROE) Capital Efficiency 5.5% N/A Higher ROE HSTM
52-Week Range Position Momentum 42% ($20โ€“$36) 4% ($7โ€“$9) Stronger Trend HSTM
Beta / 30D Volatility Risk Regime 0.38ฮฒ ยท 44% Vol 0.37ฮฒ ยท 13% Vol Lower Realized Risk SABA
Unified Institutional Score Composite Signal 50.5 / 100 (HOLD) 44.2 / 100 (HOLD) Higher Composite HSTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HSTM vs SABA Buy Guide
HSTM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live HSTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SABA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SABA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HSTM nor SABA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.